SCHEMBL22041111

SCHEMBL22041111

O=C(O)c1ccn(C(=O)N2CCN(Cc3cccc(Oc4ccc(C(F)(F)F)cn4)c3)CC2O)n1

nearest known ligand 0.85

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 14/20 0.85
FAAH O00519 8/20 0.78

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30420842 0.92 MGLL (1.00) MGLLFAAH
SCHEMBL20566934 0.92 MGLL (1.00) MGLLFAAH
SCHEMBL20566519 0.92 MGLL (1.00) MGLLFAAH
SCHEMBL30420379 0.92 MGLL (1.00) MGLLFAAH
SCHEMBL20566516 0.92 MGLL (1.00) MGLLFAAH
SCHEMBL22041121 0.90 MGLL (0.69) MGLLFAAH
SCHEMBL30420920 0.88 FAAH (1.00) MGLLFAAH
SCHEMBL20567142 0.88 FAAH (1.00) MGLLFAAH
SCHEMBL20567407 0.83 MGLL (0.84) MGLLFAAH
SCHEMBL20566930 0.83 MGLL (0.84) MGLLFAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020112905-A1 METHODS OF TREATING DISEASE WITH MAGL INHIBITORS LUNDBECK LA JOLLA RESEARCH CENTER, INC. (US) 2020-06-04 WO disclosed